Author Archives: Andrea Gonzalez

FDA approves first companion Dx for use with multiple NSCLC drugs

By Stacy Lawrence, Staff Writer The U.S. Food and Drug Administration has approved the Oncomine Dx Target Test from Thermo Fisher Scientific Inc. It is the first test of its kind to screen tumor samples for biomarkers associated with multiple…

FacebookTwitterGoogle+Share

Philips buying Oregon neuro EEG company Electrical Geodesics for €32.9M

By Stacy Lawrence, Staff Writer Royal Philips is slated to purchase Eugene, Ore.-based start up Electrical Geodesics Inc. to add its noninvasive brain activity monitoring and interpretation technology. The deal is expected to complement Philips existing imaging technology and neurological…

FacebookTwitterGoogle+Share

Senate health bill kills device tax, but tough sledding ahead

By Mark McCarty, Regulatory Editor The Senate health care reform bill debuted to a waiting and somewhat hostile Washington, and as expected, the legislation retains the repeal of the tax on medical devices and diagnostics found in the House bill….

FacebookTwitterGoogle+Share

Glaukos scores success with Istent Inject in study

By Omar Ford, Staff Writer Glaukos Medical Corp. is slowly proving its stent used in the treatment of glaucoma can be used as a standalone therapy, dispelling the idea the device must be used in conjunction with cataract procedures. The…

FacebookTwitterGoogle+Share

K2M finds its way through Sahara, looks to gain market share in spine

By Omar Ford, Staff Writer K2M Group Holdings Inc. is launching its Sahara Al Expandable stabilization system, the company’s first expandable offering within its interbody portfolio. Sahara adds more ammunition to the Leesburg, Va.-based company’s portfolio options and its bid…

FacebookTwitterGoogle+Share

Perkinelmer seeks to strengthen diagnostics position with $1.3B acquisition of Euroimmun

By Omar Ford, Staff Writer Perkinelmer Inc. has set its sights on beefing up its diagnostics offerings with a proposal to acquire Euroimmun Medical Laboratory Diagnostics AG, a private company, for $1.3 billion. If the deal goes through, then the…

FacebookTwitterGoogle+Share

Watson Health uses ASCO as springboard in oncology sector, still has work to do

By Stacy Lawrence, Staff Writer Watson Health is working hard to demonstrate the seriousness of its ongoing efforts in oncology, highlighting its research and customers at the recent American Society of Clinical Oncology (ASCO) conference. The Boston-based IBM business had…

FacebookTwitterGoogle+Share

Evasc gains C$10M series A round for pivotal U.S. trial of cerebral aneurysm clip

By Stacy Lawrence, Staff Writer Wide-neck bifurcations in cerebral aneurysms are among the most difficult to treat. Vancouver start up Evasc Neurovascular Enterprises ULC has developed the Eclips Aneurysm Remodeling System; it’s expected to offer a potential new standard-of-care, particularly…

FacebookTwitterGoogle+Share

Stryker boosts 3-D printing manufacturing efforts with GE Additive partnership

By Stacy Lawrence, Staff Writer Orthopedics giant Stryker Corp. has long been committed to advancing 3-D printing in its manufacturing. It has completed a facility dedicated to 3-D manufacturing in Carrigtohill, County Cork, Ireland, and is now in the midst…

FacebookTwitterGoogle+Share

Centogene nabs €25M to go global with genetic diagnostics for rare diseases

By Stacy Lawrence, Staff Writer Centogene AG already has revenues from patient use of its expansive genetic testing portfolio for orphan disease patients – as well as from biopharma partnerships including a deal with rare disease specialist Shire plc. Now,…

FacebookTwitterGoogle+Share

Marketo